Peter McCusker is an experienced news and business editor, who believes it’s time to fully embrace the multiple, proven, medical benefits of the cannabis plant.
By Liebe Griebenauw and Peter McCusker
FOUR firms have been sanctioned in the latest crackdown by the United States Food and Drug Administration on businesses...
FOLLOWING its recent purchase of UK cannabis firm EMMAC Life Sciences, Curaleaf has now secured an additional $130m from a single institutional investor to...
FAST-GROWING UK CBD business Love Hemp has unveiled plans to list on the London Stock Exchange backed by an over-subscribed £5m fundraise.
Founded by schoolboy...
THE marketplace entrepreneurs behind the mellow platform are diversifying with the launch of a new e-commerce service for partner brands.
James Storie-Pugh and Neil Tunbridge...
THE European medicinal cannabis supply stranglehold once enjoyed by Canada and the Netherlands is being disrupted, concludes Prohibition Partners in the sixth edition of...
AN ambitious London-headquartered private-equity acquisition vehicle has debuted with the purchase of a US CBD firm - as it sets out its global ‘buy-and-build’...